A review on antidepressant activity of Agomelatine
Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2016, Vol 4, Issue 1
Abstract
Agomelatine, a melatonergic antidepressant with a rapid onset of action, is one of the most recent drugs in the antidepressant category. Agomelatine’s antidepressant actions are attributed to its sleeppromoting and chronobiotic actions mediated by MT1 and MT2 receptors present in the suprachiasmatic nucleus, as well as to its effects on the blockade of 5-HT2c receptors. It acts on MT1 and MT2 receptors normalizing the disturbed circadian rhythms and disrupted sleep-wake cycles, apart from inhibiting 5HT-2C receptor involved in the mood, motor and cognitive deficits associated with depressive states. It is an effective alternative for patients who do not respond to or cannot tolerate currently available antidepressant agents. Subsequent comprehensive pharmacological evaluation and extensive clinical trials, agomelatine was granted marketing authorization in 2009 for the treatment of major depression in Europe, thereby becoming the first approved antidepressant to incorporate a non-monoaminergic mechanism of action. This article reviews the significance and pharmacological aspects of a novel atypical antidepressant drug, agomelatine.
Authors and Affiliations
Vivek P Chavda, Sandip Maru
Evaluation of anti arthritic activity of aqueous extract of Hibiscus Platinifolius in albino rats
Rheumatoid arthritis is a chronic, inflammatory disorder that may affect many tissues and organs, but principally attacks flexible (synovial) joints. The process produces an inflammatory responses of the capsule around...
Assessment of Hepatoprotective Potential of Solanum xanthocarpum (whole plant) Linn. Against Isoniazid & Rifampicin Induced Hepatic Toxicity in Wistar rats
Introduction and objective: The scientific assessment of medicinal plants used in the preparation of folk remedies has contributed modern medicine with effective pharmaceuticals for the treatment of diseases. Objective...
MICROENCAPSULATION TECHNOLOGY
Microparticulate drug delivery systems provide tremendous opportunities for designing new controlled and delayed release oral formulations, thus extending the frontier of future pharmaceutical development. The Micropar...
A simple validated UV spectrophotometric method for quantitative analysis of Levetiracetam in pharmaceutical dosage form
In the present study simple, precise, accurate, economical and reliable UV spectrophotometric method has been developed for the estimation of Levetiracetam in tablet dosage form. The drug shows maximum absorption (maxi...
Analytical method development for the simultaneous estimation of Hydrochlorothiazide and Atenolol in combined tablet formulation by RP-HPLC
A Simple, accurate, rapid, sensitive and precise Rp-Hplc method has been developed for estimation of Hydrochlorothiazide and Atenolol in tablet dosage form using PDA detector. A Reverse phase Thermo Hypersil ODS c18 co...